396 results on '"Ibrahim, Nasrien E."'
Search Results
2. Achieving Health Equity in the Care of Patients with Heart Failure
3. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
4. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
5. Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association
6. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
7. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
8. Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy
9. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
10. Temporal Changes in Racial and Ethnic Disparities in the Utilization of Left Atrial Appendage Occlusion in the United States
11. Organ Donation and Transplantation among Non-US Citizens: Opportunities to Improve Global Equity in Heart Transplantation
12. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
13. Is it time to revisit ICD indications?
14. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates
15. The Impact of Health Care Disparities on Patients With Heart Failure
16. Challenges and the innovations in the care of advanced heart failure patients during COVID-19
17. Diagnosis and Management of Acute Heart Failure
18. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study
19. Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock
20. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
21. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
22. Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
23. Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction
24. The Wallet Biopsy: Medical Crowdfunding for Heart Transplantation.
25. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea
26. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper
27. As We Embark on a Second Year
28. NT-proBNP Concentrations in the Community
29. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death
30. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
31. Diagnosis and Management of Acute Heart Failure
32. Correction to: Is it time to revisit ICD indications?
33. Biomarkers and Precision Medicine in Heart Failure
34. Contributors
35. Habits Heart App for Patient Engagement in Heart Failure Management: Pilot Feasibility Randomized Trial
36. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
37. Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction
38. Readability and Accessibility of Patient-Education Materials for Heart Failure in the United States
39. Abstract 16910: High-Frequency In-Person Visits During Clinical Trial Enrollment is Associated With Relative Reduction in Event Rates in Heart Failure Patients Followed Longitudinally
40. Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
41. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study)
42. Proteomic Signatures During Treatment in Different Stages of Heart Failure
43. The Quagmire of Prognostication in Heart Failure
44. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
45. Monitoring Biomarkers in Patients Receiving Neprilysin Inhibitors
46. Sex Differences in the Management of Advanced Heart Failure
47. Physicians’ Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors
48. The Gatekeepers to Transplantation: Who Are We Keeping Out?
49. NT-proBNP Concentrations in the Community
50. Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.